|
CEP350 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.530000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.496100E-02 |
| Normal-vs-Stage2 |
2.337200E-01 |
| Normal-vs-Stage3 |
7.587000E-01 |
| Normal-vs-Stage4 |
6.056000E-01 |
| Stage1-vs-Stage2 |
8.720200E-01 |
| Stage1-vs-Stage3 |
2.807800E-02 |
| Stage1-vs-Stage4 |
1.585920E-02 |
| Stage2-vs-Stage3 |
1.675650E-01 |
| Stage2-vs-Stage4 |
1.346810E-01 |
| Stage3-vs-Stage4 |
8.170400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.958620E-01 |
| Normal-vs-AfricanAmerican |
3.680200E-01 |
| Normal-vs-Asian |
2.870200E-02 |
| Caucasian-vs-AfricanAmerican |
3.826200E-02 |
| Caucasian-vs-Asian |
1.857610E-01 |
| AfricanAmerican-vs-Asian |
2.148400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.090200E-01 |
| Normal-vs-Female |
2.799600E-01 |
| Male-vs-Female |
8.471200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.985800E-01 |
| Normal-vs-Age(41-60Yrs) |
9.992400E-02 |
| Normal-vs-Age(61-80Yrs) |
5.392000E-01 |
| Normal-vs-Age(81-100Yrs) |
6.553200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.023200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.600000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.965000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.973970E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.729200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.749400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.915530E-02 |
| Normal-vs-Grade 2 |
1.578210E-02 |
| Normal-vs-Grade 3 |
8.393200E-01 |
| Normal-vs-Grade 4 |
5.567400E-01 |
| Grade 1-vs-Grade 2 |
4.669800E-01 |
| Grade 1-vs-Grade 3 |
1.930080E-02 |
| Grade 1-vs-Grade 4 |
3.118400E-02 |
| Grade 2-vs-Grade 3 |
1.876080E-03 |
| Grade 2-vs-Grade 4 |
7.679700E-03 |
| Grade 3-vs-Grade 4 |
6.082200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.179000E-03 |
| Normal-vs-ccB subtype |
9.745400E-01 |
| ccA subtype-vs-ccB subtype |
1.063230E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.489400E-01 |
| Normal-vs-N1 |
3.824000E-01 |
| N0-vs-N1 |
5.776000E-01 |
|
|
